JMPWA
QNCX icon

JP Morgan Private Wealth Advisors’s Quince Therapeutics QNCX Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-42
Closed -$387K – 1619
2020
Q2 		$387K Hold
42
– – ﹤0.01% 1213
2020
Q1 		$381K Buy
+42
New +$415K ﹤0.01% 1040

Other funds holding QNCX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Private Wealth Advisors's QNCX Position: Q3 2020 in Review

JP Morgan Private Wealth Advisors sold out of Quince Therapeutics (QNCX) in Q3 2020, closing a stake of 42 shares — an estimated $387K sold.

JP Morgan Private Wealth Advisors first reported a position in QNCX in Q1 2020 and held it in 2 quarters. The position peaked at $387K in Q2 2020. 79 funds tracked by Wall St. Rank hold QNCX as of Q3 2020.

  • JP Morgan Private Wealth Advisors reported no remaining Quince Therapeutics position as of Q3 2020 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 42 Quince Therapeutics shares in Q3 2020, an estimated $387K.
  • JP Morgan Private Wealth Advisors first reported a position in Quince Therapeutics in Q1 2020 and held it in 2 quarters.
  • JP Morgan Private Wealth Advisors's Quince Therapeutics position peaked at $387K in Q2 2020.
  • 79 funds tracked by Wall St. Rank held Quince Therapeutics as of Q3 2020.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.